UT Health San Antonio

• Juan Palavicini

  Lead investigator

• Jeremy Tanner

  Lead investigator

• Tiffany Kautz

  Lead investigator

• Valentina Garbarino

  Lead investigator

• Mohamad Habes

  Lead investigator

• Bowen Yang

  Lead investigator

• Debora Melo van Lent

  Lead investigator

• Gabriel de Erausquin

  Lead investigator

• Jonathan Dorigatti

  Lead investigator

Sources: openalex.org

• Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department

  Phase 2, Recruiting, 200 people, Oct 9, 2026

• NCT07842367

  Collaborator, Phase 2, Recruiting, 210 people, Sep 25, 2026

• NCT07470606

  Phase 2, Recruiting, 108 people, Mar 13, 2026

• NCT07437053

  Early phase 1, Not yet recruiting, 20 people, Feb 27, 2026

• SwallowFIT Study in Parkinson's Disease

  Not yet recruiting, 80 people, Jan 21, 2026

• The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

  Phase 1, Recruiting, 150 people, Oct 8, 2025

• Ultrasound for Healthy Aging

  Recruiting, 20 people, Sep 11, 2025

• NCT07056699

  Phase 3, Recruiting, 24 people, Jul 9, 2025

• NCT07053319

  Phase 1, Recruiting, 64 people, Jul 8, 2025

• NCT07053306

  Phase 1, Recruiting, 29 people, Jul 8, 2025

• NCT07053293

  Early phase 1, Recruiting, 22 people, Jul 8, 2025

• NCT06977711

  Phase 1, Recruiting, 10 people, May 18, 2025

• NCT06811324

  Phase 2, Recruiting, 20 people, Feb 6, 2025

• RESTOR: PK/PD mTORi Inhibition in Older Adults

  Early phase 1, Recruiting, 194 people, Oct 26, 2024

• NCT06609343

  Phase 1/2, Not yet recruiting, 16 people, Sep 24, 2024

• NCT06556095

  Early phase 1, Completed, 44 people, Aug 15, 2024

• NCT06446531

  Phase 1, Recruiting, 64 people, Jun 6, 2024

• NCT06333990

  Collaborator, Phase 3, Recruiting, 146 people, Mar 27, 2024

• NCT06246799

  Phase 3, Recruiting, 256 people, Feb 7, 2024

• NCT06229678

  Early phase 1, Recruiting, 71 people, Jan 29, 2024

Sources: clinicaltrials.gov

• Advanced Research Projects Agency for Health

  PROSPR, PROSPR: VITAL-H (Validation and Intervention Testing for Aging, Longevity and Healthspan), a phase 3 trial of rapamycin, dapagliflozin and semaglutide against placebo in 726 adults in their 60s, led by the Barshop Institute, US$38m, 2026, Feb 24, 2026

• Alzheimer's Association

  AARG, Gene-Environment Synergy: Circadian and Metabolic Triggers in MAPT-GR Mice, 26AARGA-1574562, 2026, Jan 1, 2026

• Alzheimer's Association

  BFDN, Uganda Aging and Dementia Cohort Study, 26BFDN-1579177A, 2026, Jan 1, 2026

• Alzheimer's Association

  AARG, COVID-19, 7T Imaging and AD Plasma Biomarkers, AARG-25-1487306, 2025, Jan 1, 2025

• Alzheimer's Association

  NIAP, Transcriptomic Signature for Chronic Stress Contribution to ADRD Risk, NIAP25-1446397, 2025, Jan 1, 2025

• Alzheimer's Association

  VCID-UMD, CALDN: A Contrast-Adaptive Lesion Discovery Network, VCID-UMD-26-1531655, 2025, Jan 1, 2025

• American Heart Association

  Predoctoral Fellowship, Integrative MRI and Genomics Analysis of Prenatal Steroid Exposure on Cardiac Health, 24PRE1191693, US$67.4k, 2024–2025, Jan 1, 2024

• Alzheimer's Association

  AARG, The Impact of Metabolic Signatures of the MIND Diet on Brain Aging, 24AARG-1241954, 2024, Jan 1, 2024

• Alzheimer's Association

  SG, Population-based sampling of older adults from an Amerindian population exposed to SC2 in Northern Argentina, SG-22-923249, 2022, Jan 1, 2022

• Alzheimer's Association

  AARF, The Impact of the Dietary Inflammatory Index on Brain Aging, AARF-22-918316, 2022, Jan 1, 2022

• American Heart Association

  Predoctoral Fellowship, Beta-Guanidinopropionic acid as an Intervention Targeting Health-span, 19PRE34450033, US$53.7k, 2019–2021, May 1, 2019

Sources: news.uthscsa.edu, openalex.org

• University of Texas Rio Grande Valley

  Advancing cross-national research on aging and cognitive function: English/Spanish courses with the (sub-award to THE UNIVERSITY OF TEXAS RIO GRANDE VALLEY), usaspending_subaward/ASST_NON_R25AG095799_075/L3ATVUT2KNK7, US$52.9k, 2026, Sep 29, 2026

• University of North Dakota

  Effects of leptin modulation on health span and lifespan (sub-award to UNIVERSITY OF NORTH DAKOTA), usaspending_subaward/ASST_NON_R01AG084646_075/RSWNKK6J8CF3, US$57k, 2026, Sep 25, 2026

• Arizona State University

  Advancing cross-national research on aging and cognitive function: English/Spanish courses with the (sub-award to ARIZONA STATE UNIVERSITY), usaspending_subaward/ASST_NON_R25AG095799_075/NTLHJXM55KZ6, US$37.7k, 2025, Nov 7, 2025

• Cedars-Sinai Medical Center

  Effects of leptin modulation on health span and lifespan (sub-award to CEDARS-SINAI MEDICAL CENTER), usaspending_subaward/ASST_NON_R01AG084646_075/NCSMA19DF7E6, US$37.3k, 2025, Aug 26, 2025

Sources: openalex.org

• Lung environment in healthy old age shapes the phenotype and CCR2-mediated recruitment of a subset of apoptotic, high-turnover alveolar macrophages

  Oct 7, 2026

• Aging leads to altered physiological reactivity in response to repeated social separation stress in a nonhuman primate model

  Apr 13, 2026

• Short-term mTOR inhibition by rapamycin improves cardiac and endothelial function in older men: a proof-of concept pilot study

  Sep 19, 2025

• Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial

  TR002647, May 20, 2025

• Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease

  TL1TR002647, Apr 23, 2025

• Age-Dependent Bi-Phasic Dynamics of Ly49+CD8+ Regulatory T Cell Population

  P30 CA054174, Dec 18, 2024

• Mechanisms underlying retardation of aging by dietary energy restriction

  Nov 17, 2023

• Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial

  TR002647, Sep 7, 2023

• Impact of HIV on COVID-19 Outcomes: A Propensity Score Matching Analysis with Varying Age Differences

  Jun 8, 2023

• Estradiol-independent restoration of T-cell function in post-reproductive females

  Jan 23, 2023

• Matrix-bound Cyr61/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging

  Jun 23, 2022

• Biological aging processes underlying cognitive decline and neurodegenerative disease

  May 16, 2022

• Redox regulation of age-associated defects in generation and maintenance of T cell self-tolerance and immunity to foreign antigens

  UL1 TR001120, Feb 15, 2022

• Increasing cytosolic Ca2+ levels restore cell proliferation and stem cell potency in aged MSCs

  Oct 3, 2021

• The aging lung mucosa: A proteomics study

  Sep 20, 2021

• NFκB Regulates Muscle Development and Mitochondrial Function

  P30 AG044271, Mar 9, 2020

• Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

  P30 AG044271, Jan 5, 2019

• Cause or casualty: The role of mitochondrial DNA in aging and age-associated disease

  Nov 9, 2018

• Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging

  Sep 6, 2018

• A window into extreme longevity; the circulating metabolomic signature of the naked mole-rat, a mammal that shows negligible senescence

  Apr 20, 2018

Sources: openalex.org, api.crossref.org

• Melatonin reduced senescence markers in human skin cells

  The Journal of investigative dermatology, Oct 20, 2026

• Brain scans and blood markers may help detect thinking problems

  Alzheimer's & dementia : the journal of the Alzheimer's Association, Oct 18, 2026

• Irregular blood pressure patterns linked to dementia

  Journal of the American Heart Association, Oct 16, 2026

• Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity

  Journal of the American Heart Association, Oct 16, 2026

• Osteoporosis medication initiation after proximal humerus fractures is low, but associated with decreased secondary fragility fracture risk

  OTA international : the open access journal of orthopaedic trauma, Oct 9, 2026

• Old lung environment changes immune cell traits in mice

  Nature communications, Oct 7, 2026

• Coronary artery disease and neurocognitive performance among older adults in Uganda

  Research square, Oct 2, 2026

• Brain small vessel disease links to stroke and mortality risk

  medRxiv : the preprint server for health sciences, Oct 2, 2026

• Tablet test detects cognitive impairment in older Ugandans

  medRxiv : the preprint server for health sciences, Oct 2, 2026

• GLP-1 receptor agonists link to lower stroke and Alzheimer risk

  Neurology. Genetics, Oct 1, 2026

• Autologous cytokine-induced NK cells as candidate cellular senolytics: evidence, obstacles, and the experiments still needed

  GeroScience, Sep 30, 2026

• Lewy body disease tracks with cognitive decline and psychosis

  Movement disorders : official journal of the Movement Disorder Society, Sep 28, 2026

• Associations of Elevated Lipoprotein(a) with C-Reactive Protein and Type 2 Diabetes in a Multiethnic Population

  Biomedicines, Sep 26, 2026

• Serum metabolite signature of the mediterranean diet adherence and cognitive function: Evidence from two cohorts

  Clinical nutrition (Edinburgh, Scotland), Sep 26, 2026

• The Association Between Residential Movement and Successful Aging: Evidence from the Korean Longitudinal Study of Aging

  Journal of aging & social policy, Sep 26, 2026

• Cognition in Cardiovascular Disease

  Current neurology and neuroscience reports, Sep 24, 2026

• mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimer's disease

  bioRxiv : the preprint server for biology, Sep 24, 2026

• Soluble pathogenic tau transmission to astrocytes drives cellular senescence and neurovascular uncoupling in a model of Alzheimer's tauopathy

  bioRxiv : the preprint server for biology, Sep 24, 2026

• Associations of Brain Structure and Neuropsychological Function With Artificial Intelligence Estimates of Biological Vascular Age

  Arteriosclerosis, thrombosis, and vascular biology, Sep 24, 2026

• Targeting α5-GABAA receptors to restore dopamine system function in a translationally relevant model of perimenopausal psychosis

  Psychopharmacology, Sep 23, 2026